EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Septic Cardiomyopathy and Mitochondrial Quality Control

Xiangyi Pu, Zhaoqi Yan, Zhiming Liu, Xing Chang, Ruxiu Liu

Frontiers in Bioscience-Landmark · 2026

DOI: 10.31083/fbl47390 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, 2026. Verfasst von Xiangyi Pu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, 100053 Beijing, China. Hauptthemen laut MEDLINE: Sepsis, Cardiomyopathies, Mitochondria, Heart. Die Arbeit nennt 247 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academic Inheritance and Communication Project of China Academy of Chinese Medical Sciences, Clinical Research Fund of Central High-Level Traditional Chinese Medicine Hospitals: Hospital Preparation Project Based on the Experience of Renowned Tradition…, Beijing Traditional Chinese Medicine Inheritance Project "New 3+3" - Zhimin Liu Three-Famous Inheritance Studio.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Septic cardiomyopathy (SCM) is a prevalent and serious cardiac complication arising from sepsis-induced multiple organ dysfunction syndrome (MODS). The pathogenesis of SCM is complex and primarily involves immune-inflammatory responses, oxidative stress, programmed cell death, and mitochondrial dysfunction. In recent years, mitochondrial quality control (MQC) has attracted growing interest as a central mechanism for maintaining cellular homeostasis and myocardial energy metabolism in SCM. This review systematically summarizes recent advances in four key MQC mechanisms involved in SCM: (1) phosphatase and tensin homolog-induced putative kinase 1 (PINK1)/Parkin-mediated mitophagy; (2) mitochondrial dynamics, including dynamin-related protein 1 (Drp1)/fission protein 1 (FIS1)-driven fission and optic atrophy protein 1 (OPA1)/mitofusin (MFN)-regulated fusion; (3) mitochondrial biogenesis under the regulatory control of the peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1α)/nuclear respiratory factor 1 (NRF1)/mitochondrial transcription factor A (TFAM) axis; and (4) the mitochondrial unfolded protein response (UPRmt), which maintains mitochondrial proteostasis through mediators such as C/EBP homologous protein (CHOP), YME1-like protease (YME1L), and Overlapping activity with m-AAA protease 1 (OMA1). These mechanisms have been shown to work synergistically to regulate mitochondrial clearance, renewal, and functional maintenance. Any imbalance among them can exacerbate myocardial injury. This review also emphasizes the redox crosstalk between oxidative stress and immune inflammation, with an emphasis on the pivotal contributions of NADPH oxidase 2 (NOX2), high mobility group box 1 (HMGB1), and the nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3 (NLRP3) inflammasome in vascular endothelial dysfunction and cardiac depression. In conclusion, preserving the dynamic equilibrium of MQC is crucial for preventing or reversing SCM and may present novel molecular targets and therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SepsisCardiomyopathiesMitochondria, HeartHumansAnimalsMitophagyOxidative StressMitochondrial DynamicsUnfolded Protein Response

Stichwörter der Autor:innen

cardiomyopathiesinflammationmitochondrial dynamicsmitochondrial dysfunctionmitophagyoxidative stresssepsis

Autor:innen und Institutionen

  • Internal Medicine of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, 100053 Beijing, China.

Förderung

  • Academic Inheritance and Communication Project of China Academy of Chinese Medical Sciences
  • Clinical Research Fund of Central High-Level Traditional Chinese Medicine Hospitals: Hospital Preparation Project Based on the Experience of Renowned Tradition…
  • Beijing Traditional Chinese Medicine Inheritance Project "New 3+3" - Zhimin Liu Three-Famous Inheritance Studio
  • Beijing Traditional Chinese Medicine Inheritance Project "New 3+3" - Zhimin Liu's Disciple (Ruxiu Liu) Inheritance Studio
  • Beijing Traditional Chinese Medicine Inheritance Project “New 3+3” – Zhimin Liu Three-Famous Inheritance Studio
  • Beijing Traditional Chinese Medicine Inheritance Project “New 3+3” – Zhimin Liu’s Disciple (Ruxiu Liu) Inheritance Studio

Zitieren

APA

Pu, X., Yan, Z., Liu, Z., Chang, X., & Liu, R. (2026). Septic Cardiomyopathy and Mitochondrial Quality Control. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl47390

Vancouver

Pu X, Yan Z, Liu Z, Chang X, Liu R. Septic Cardiomyopathy and Mitochondrial Quality Control. Frontiers in Bioscience-Landmark. 2026. doi:10.31083/fbl47390

BibTeX
@article{Pu2026,
  author = {Pu, Xiangyi and Yan, Zhaoqi and Liu, Zhiming and Chang, Xing and Liu, Ruxiu},
  title = {Septic Cardiomyopathy and Mitochondrial Quality Control},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2026},
  doi = {10.31083/fbl47390}
}
Kostenlos starten →